DUBLIN, March 31, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a fireside chat at the Jones Healthcare and Technology Innovation Conference in Las Vegas on ...

“During 2024 and Q1 2025, we made significant progress shaping the company for success,” said Daniel Passeri, chief executive officer of Cue Biopharma (CUE). “We believe that the ongoing ...

Wedbush initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $35 price target Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed ...

Novo is paying up to $1 billion for a “non-incretin” medicine that might boost Wegovy’s effects. Elsewhere, Arbutus laid off ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect” or the “Company”), a ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

GC Biopharma announced on the 14th that it received approval from the Ministry of Food and Drug Safety for the clinical trial plan (IND) for an adult combined vaccine against tetanus, diphtheria ...

The finalists for the biopharma track of INVEST Pitch Perfect have been selected. At the INVEST Pitch Perfect boutique healthcare investor conference, six biopharma companies will present their ...

Biotech firm Quantum BioPharma said on March 20 that it had now spent $3.5 million in total to buy BTC and other cryptocurrencies after an initial $1 million investment in December. Medical ...

HANALL BIOPHARMA announced on the 18th that it has notified Harbor BioMed of the termination of the license agreement for the autoimmune disease treatment 'batoclimab (HL161).' HANALL BIOPHARMA ...

On Tuesday, Bernstein released a report detailing the complexities of tariff risks within the biopharma sector and its potential impact on major companies. The analysis aims to unravel the ...

At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting for nearly a third of those rounds. The cuts were accompanied by eight ...